Quest PharmaTech

OTC-QPTFF
OTCMKTS
Healthcare Biotechnology
Global Rank
#48089
Country Rank
#2327
Market Cap
2.41 M
Price
0.02
Change (%)
0.00%
Volume
350,000

Quest PharmaTech's latest marketcap:

2.41 M

As of 07/19/2026, Quest PharmaTech's market capitalization has reached $2.41 M. According to our data, Quest PharmaTech is the 48089th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.41 M
Revenue (ttm) 0
Net Income (ttm) 3.68 M
Shares Out 0
EPS (ttm) 0.02
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 09/23/2026
Market Cap Chart
Data Updated: 07/19/2026

Quest PharmaTech's yearly market capitalization.

Quest PharmaTech has seen its market value drop from $3.28 M to $2.41 M since 2014, representing a total decrease of 26.41% and an annual compound decline rate (CAGR) of 2.62%.
Date Market Cap($) Change (%) Global Rank
07/19/2026 $2.41 M 15.21% 48089
12/30/2025 $4.33 M 22.69% 47203
12/30/2024 $3.53 M -49.98% 46910
12/28/2023 $7.05 M -13.23% 45249
12/30/2022 $8.12 M -35.69% 43547
12/31/2021 $12.63 M -58.29% 41576
12/31/2020 $30.28 M 81.67% 38433
12/30/2019 $16.67 M 35.87% 35824
12/31/2018 $12.27 M -12.31% 34481
12/29/2017 $13.99 M 4.1% 33012

Company Profile

Quest PharmaTech Inc.

Company Overview: Quest PharmaTech Inc. is a pharmaceutical company focused on developing novel therapeutics for targeted cancer treatments.

Key Product Candidates

  • Mab AR 9.6: Targets truncated O-glycan on MUC16, with potential applications in pancreatic, colon, leukemia, ovarian, and breast cancer.
  • Oregovomab: Currently in Phase III clinical trials for ovarian cancer treatment.

Headquarters: Edmonton, Canada.

Frequently Asked Questions

  • What is Quest PharmaTech's (OTC-QPTFF) current market cap?
    As of 07/19/2026, Quest PharmaTech (including the parent company, if applicable) has an estimated market capitalization of $2.41 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Quest PharmaTech global market capitalization ranking is approximately 48089 as of 07/19/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.